According to the current analysis of Reports and Data, the Global Artificial urethra market is expected to reach USD 841.44 million by the year 2026, in terms of value at a CAGR of 12.5%. The efflux of urine is a common condition, which affects the patient's quality-of-life. Incontinence may arise as a consequence of a weakness of the urinary bladder or sphincter dysfunction, usually over-activity. The artificial urethra also called as artificial urinary sphincter consists of a cuff or ring that is placed around the urethra. There is a pump placed in the wall of the scrotum which can be manually squeezed. Upon squeezing the pump, fluid is shifted from the cuff to a balloon or reservoir that is placed behind the abdominal muscles.

Increase in investments in the market, which are supporting the technological advancements, and rise in healthcare expenditure are estimated to shape the growth of the artificial urethra market. The technological advancements in the artificial urethra include development of enhanced silicone rubber designs, advanced slings, and other flow securing devices. Due to these advancements in recent times, artificial urethras have demonstrated lesser adverse effects and greater efficacy and symptomatic relief in patients with prostate gland disorders as compared to conventional methods. Likewise, the potential benefits of artificial urethra therapy, such as long-term efficacy for 10 to 15 years, are projected to facilitate growth over the study period.

Furthermore, these advancements aid clinical researchers and physicians in investigational efficacy studies for the usage of artificial urethra off-label clinical applications such as prostate cancer. The flow Secure artificial urinary sphincter is a new prosthesis for the management of urinary incontinence due to Intrinsic urethral sphincter deficiency (ISD). Indications for implantation of the Flow Secure device in order of significance are post-prostatectomy urinary incontinence, incontinence due to congenital abnormalities, neurogenic bladder with ISD, and stress incontinence. The different and novel products in artificial urethra market designed for implantation in pediatric patients to treat deficient bladder sphincter function are expected to drive the demand of artificial urethra in the analysis period. The ZSI 375 for instance, has the advantage to increase the permitted pressure and allows the user to readjust the cuff. Various new types of the artificial sphincter are being developed using a spring-loaded mechanism for applying circumferential pressure in the urethra, which is easy to implant and simple to use. These product development initiatives undertaken by various companies are anticipated to bolster the artificial urethra market growth in the forecast period.

In-depth Study of the Competitive Landscape:

The global Artificial Urethra market consists of various market players, which make this business sphere highly competitive. In this section of the report, the authors have provided authentic information on product portfolios, new product innovations, technological capabilities, and product pricing strategies of each of these players. Moreover, it discusses the key strategies implemented by these players, such as mergers acquisitions, joint ventures, collaborations, partnerships and agreements, to build on their market presence.

Top companies profiled in the report include:

Boston Scientific Corporation, Zephyr Surgical Implants, GT Urological, Myopowers Medical Technologies SAS, and Promedon

Key Market Regions Covered in the Report:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

By Product: (Revenue, USD Million; 2016-2026)

• Silicone elastomers
• Others

By Incontinence Type (Revenue, USD Million; 2016-2026)

• Stress Incontinence
• Urge Incontinence
• Overflow Incontinence
• Functional Incontinence

By Sales channel (Revenue, USD Million; 201-2026)

• Channel sales
• Direct sales

By End-user: (Revenue, USD Million; 2016-2026)

• Hospitals
• Specialty Clinics
• Research institutes

Frequently asked questions addressed in the report:

• What is the revenue growth rate of the global Artificial Urethra market over the forecast period?
• What are the major factors driving the growth of the Global Artificial Urethra Market?
• What are the key challenges impacting the global Artificial Urethra market growth?
• What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report?

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1936 

Thank you for reading our report. Do connect with us in case of any more queries about the report and its customization. Our team will ensure the report is well suited to cater to your needs.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.